• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Novo Nordisk: Research Scientist, Seattle WA

CP Staff

Administrator
Staff member
To provide technical expertise and execute laboratory research strategies in support of multiple in vivo and in vitro projects focused on expedited evaluation and the clinical translation of therapies for type 1 diabetes and kidney disease. This position will be responsible for providing peer leadership and technical support in the laboratory for research experiments and data integrity.

Job Details